| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | — | — | — | — | — | — | — | — | — |
| Sell | — | — | — | — | 3 | — | — | — | — | — | — | — |
| total | individual payouts | |
|---|---|---|
| 2028 | ‡‡‡‡‡ |
|
| 2027 | ‡‡‡‡‡ |
|
| 2026 | 1.91 |
—
—
—
|
| 2025 | 1.70 |
—
—
—
—
|
| 2024 | 1.50 |
—
—
—
—
|
| 2023 | 1.30 |
—
—
—
—
|
| 2022 | 1.10 |
—
—
—
—
|
| 2021 | 0.60 |
—
—
—
—
|
| 2020 | 1.22 |
—
—
—
—
|
| 2019 | 1.92 |
—
—
—
—
|
| 2018 | 1.64 |
—
—
—
—
|
| 2017 | 1.54 |
—
—
—
—
|
| 2016 | 1.52 |
—
—
—
—
|
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Cash | 414,977.00 | 477,286.00 | 596,074.00 | 651,888.00 |
| Receivables | — | — | — | — |
| Inventory | — | — | — | — |
| Other | — | — | — | — |
| 1,341,989.00 | 1,375,848.00 | 1,568,444.00 | 1,669,098.00 |
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Payables | 1,358,173.00 | 1,371,804.00 | 1,426,207.00 | 1,501,405.00 |
| ST’ Debt | — | — | — | — |
| Other | — | — | — | — |
| 1,518,942.00 | 1,530,888.00 | 1,745,413.00 | 1,861,108.00 |
| 10y | 5y | 3y | |
| Sales | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | ‡‡‡ | ‡‡‡ | ‡‡‡ |
| Earnings | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Book Value | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 31,795.00 | 33,589.00 | — | — |
—
|
| ’25 | 29,627.00 | 30,434.00 | 31,905.00 | 31,563.00 |
123,529.00
|
| ’24 | 31,476.00 | 31,650.00 | 31,674.00 | 30,597.00 |
125,397.00
|
| ’23 | 26,749.00 | 28,200.00 | 29,845.00 | 30,546.00 |
115,340.00
|
| ’22 | 18,688.00 | 18,398.00 | 21,962.00 | 24,394.00 |
83,442.00
|
| ’21 | 19,770.00 | 21,163.00 | 19,759.00 | 22,389.00 |
83,081.00
|
| ’20 | 21,132.00 | 20,207.00 | 20,748.00 | 20,140.00 |
82,227.00
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 9,143.00 | 6,775.00 | — | — |
—
|
| ’25 | (11,037.00) | (11,216.00) | (869.00) | 4,121.00 |
(19,001.00)
|
| ’24 | (12,125.00) | 2,050.00 | 4,206.00 | 8,904.00 |
3,035.00
|
| ’23 | 7,406.00 | (755.00) | 15,505.00 | 18,202.00 |
40,358.00
|
| ’22 | 199.00 | 7,588.00 | 12,016.00 | 7,245.00 |
27,048.00
|
| ’21 | (3,470.00) | (8,062.00) | (4,810.00) | 4,817.00 |
(11,525.00)
|
| ’20 | 17,273.00 | 16,119.00 | (8,576.00) | (22,765.00) |
2,051.00
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 9,143.00 | 6,775.00 | — | — |
—
|
| ’25 | (11,037.00) | (11,216.00) | (869.00) | 4,121.00 |
(19,001.00)
|
| ’24 | (12,125.00) | 2,050.00 | 4,206.00 | 8,904.00 |
3,035.00
|
| ’23 | 7,406.00 | (755.00) | 15,505.00 | 18,202.00 |
40,358.00
|
| ’22 | 199.00 | 7,588.00 | 12,016.00 | 7,245.00 |
27,048.00
|
| ’21 | (3,470.00) | (8,062.00) | (4,810.00) | 4,817.00 |
(11,525.00)
|
| ’20 | 17,273.00 | 16,119.00 | (8,576.00) | (22,765.00) |
2,051.00
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 1.60 | 2.00 | — | — |
—
|
| ’25 | 1.39 | 1.60 | 1.66 | 1.62 |
6.26
|
| ’24 | 1.20 | 1.33 | 1.42 | 1.43 |
5.37
|
| ’23 | 1.23 | 1.25 | 1.48 | 0.86 |
4.83
|
| ’22 | 0.88 | 0.74 | 0.85 | 0.67 |
3.14
|
| ’21 | 1.05 | 1.38 | 1.17 | 1.38 |
4.95
|
| ’20 | 0.01 | (0.66) | 0.42 | 0.64 |
0.41
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | 36.54 | 35.25 | 46.12 | 58.42 | — | — | — |
Low Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 60.30 | 50.77 | 78.13 | 95.85 | — | — | — |
High Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 238,000 | 226,000 | 217,000 | 205,000 | — | — | — |
Employees
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.35 | 0.51 | 0.58 | 0.60 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 83,442.00 | 115,340.00 | 125,397.00 | 123,529.00 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 89.13% | 71.61% | 65.63% | 67.76% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 15,629.00 | 21,636.00 | 23,364.00 | 25,199.00 | — | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 18.73% | 18.76% | 18.63% | 20.40% | ‡‡‡ | ‡‡‡ | ‡‡‡ |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 13,378.00 | 19,029.00 | 19,965.00 | 21,358.00 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 6,832.00 | 6,271.00 | 7,558.00 | 7,713.00 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 21.93 | 31.27 | 36.60 | 38.58 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue/Sh
|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | 3.17 | 4.88 | 5.43 | 6.34 | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 7.11 | 10.94 | 0.89 | (5.93) | — | — | — |
Cash Flow/Sh
|
| ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | 0.00 | 0.00 | 0.00 | 0.00 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 7.11 | 10.94 | 0.89 | (5.93) | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 47.89 | 50.82 | 52.85 | 57.17 | ‡‡‡‡ | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3,805.20 | 3,688.30 | 3,426.10 | 3,201.80 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Shares
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 13.14 | 10.15 | 12.91 | 14.70 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
PE Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.91 | 1.58 | 1.92 | 2.42 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PS Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.98 | 1.08 | 1.48 | 1.79 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PB Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.12 | 0.65 | 0.30 | (0.18) | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
EV/Sales
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3.46 | 1.87 | 12.88 | 1.16 | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 27,048.00 | 40,358.00 | 3,035.00 | (19,001.00) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Op' Cash Flow
|
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 27,048.00 | 40,358.00 | 3,035.00 | (19,001.00) | — | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (240,532.00) | (176,953.00) | (155,040.00) | (176,969.00) | — | — | — |
Working Cap'
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 247,405.00 | 207,588.00 | 173,078.00 | 174,712.00 | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (65,943.00) | (207,389.00) | (304,208.00) | (421,362.00) | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 182,213.00 | 187,443.00 | 181,066.00 | 183,038.00 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.66% | 0.94% | 0.96% | 0.99% | — | — | — |
ROA
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 8.40% | 0.00% | 0.00% | 0.00% | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 7.55% | 10.87% | 11.26% | 12.34% | — | — | — |
ROE
|
Wells Fargo (WFC) has demonstrated notable resilience after a decade of challenges, including the 2016 fake accounts scandal, pandemic-induced losses, and a Federal Reserve asset cap that stifled growth until its lifting in early 2024. This regulatory relief coincides with sharp efficiency gains—employee headcount down 19% since 2016, driving revenue per employee up 65% to $578,000—fueling revenue surges from $83.4 billion in 2022 to a projected $125.4 billion in 2024. Profitability is rebounding, with EPS poised to climb 151% from 2022 lows to nearly $8 by 2027, supported by share buybacks and stabilizing ROE at 11.3%.
The balance sheet stands as a fortress, with total debt slashed 55% to $173 billion and net debt deeply negative at -$422 billion, providing ample liquidity amid banking sector volatilities. Valuation metrics scream cautionary value: PE at 12.9, PB at 1.48, and analyst targets implying 18% upside from recent levels, though revenue projections show cyclical dips in 2025-2026 due to anticipated rate cuts.
While WFC’s transformation into an efficiency-focused steady performer offers mid-teens return potential, downside risks loom from credit losses, deposit competition, and commercial real estate exposure. Investors should scrutinize this undervalued recovery play against macro headwinds before committing.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.